Front & Back Matter.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. X, doi. 10.1159/000381837
- Publication type:
- Article
Works matching IS 00086312 AND DT 2015 AND VI 130 AND IP 3
Results: 14
1
2
Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 137, doi. 10.1159/000369247
- By:
- Publication type:
- Article
3
KLF15 Is an Essential Negative Regulatory Factor for the Cardiac Remodeling Response to Pressure Overload.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 143, doi. 10.1159/000369382
- By:
- Publication type:
- Article
4
The Effect of Carvedilol on B-Type Natriuretic Peptide and Cardiac Function in Patients with Heart Failure and Persistent Atrial Fibrillation.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 153, doi. 10.1159/000368746
- By:
- Publication type:
- Article
5
Arrhythmogenic Right Ventricular Cardiomyopathy with Left Ventricular Involvement: A Novel Splice Site Mutation in the DSG2 Gene.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 159, doi. 10.1159/000369057
- By:
- Publication type:
- Article
6
We Need to Rethink about Prophylactic Perioperative β-Blocker Therapy for Takotsubo Syndrome.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 162, doi. 10.1159/000370029
- By:
- Publication type:
- Article
7
Comment on the Paper by Su et al. Entitled 'Safety and Efficacy of Warfarin plus Aspirin Combination Therapy for Giant Coronary Artery Aneurysm Secondary to Kawasaki Disease: A Meta-Analysis'.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 164, doi. 10.1159/000369879
- By:
- Publication type:
- Article
8
Author's Reply.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 166, doi. 10.1159/000370104
- By:
- Publication type:
- Article
9
Common Genetic Variants and Risk of Ischemic Heart Failure: An Evaluation of a Negative Genetic Study.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 167, doi. 10.1159/000369447
- By:
- Publication type:
- Article
10
A Vasodilator Is a Vasodilator Is a Vasodilator?
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 169, doi. 10.1159/000370105
- By:
- Publication type:
- Article
11
Exercise-Induced Cardioprotection: More to k'NO'w.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 172, doi. 10.1159/000375399
- By:
- Publication type:
- Article
12
Nitric Oxide Synthase Inhibition Abolishes Exercise-Mediated Protection against Isoproterenol-Induced Cardiac Hypertrophy in Female Mice.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 175, doi. 10.1159/000370025
- By:
- Publication type:
- Article
13
Acknowledgement to the Reviewers.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 185, doi. 10.1159/000380791
- Publication type:
- Article
14
The Shortcomings of Clinical Practice Guidelines.
- Published in:
- Cardiology, 2015, v. 130, n. 3, p. 187, doi. 10.1159/000371572
- By:
- Publication type:
- Article